Insights

Innovative Genetic Medicines 4D Molecular Therapeutics is developing innovative genetic medicines to treat a wide range of diseases using a vector discovery platform that creates customized and evolved vectors with improved therapeutic profiles. This cutting-edge technology presents a unique opportunity for the company to position itself as a leader in the genetic medicine space.

Expanding Product Pipeline With five product candidates in clinical trials for seven patient populations, 4D Molecular Therapeutics has a robust product pipeline that offers diverse solutions for various medical needs. This breadth of offerings provides multiple entry points for sales, catering to different market segments and patient populations.

Key Team Additions The recent appointment of Uneek Mehra as Chief Financial & Business Officer brings a fresh perspective and expertise to 4D Molecular Therapeutics. Leveraging new leadership can open doors to strategic partnerships, funding opportunities, and expanded market reach, creating avenues for enhanced sales growth.

Positive Financial Outlook With revenue ranging between $10M - $50M and funding amounting to $300M, 4D Molecular Therapeutics showcases financial stability and growth potential. This strong financial foundation provides a solid basis for sales teams to negotiate deals, secure investments, and explore expansion opportunities.

Competitive Landscape Analysis By assessing similar companies such as Graphite Bio, LogicBio Therapeutics, and Generation Bio, sales development representatives can gain insights into market positioning, employee size, and revenue benchmarks within the biotechnology research industry. This competitive analysis arms sales teams with strategic intelligence to differentiate and capture market share effectively.

4D Molecular Therapeutics Tech Stack

4D Molecular Therapeutics uses 8 technology products and services including Power BI, Microsoft Word, RSS, and more. Explore 4D Molecular Therapeutics's tech stack below.

  • Power BI
    Business Intelligence
  • Microsoft Word
    Editors
  • RSS
    Miscellaneous
  • Open Graph
    Miscellaneous
  • Microsoft
    Miscellaneous
  • Kinsta
    Platform As A Service
  • Amazon Web Services
    Platform As A Service
  • Yoast SEO
    Search Engines

Media & News

4D Molecular Therapeutics's Email Address Formats

4D Molecular Therapeutics uses at least 1 format(s):
4D Molecular Therapeutics Email FormatsExamplePercentage
FLast@4dmoleculartherapeutics.comJDoe@4dmoleculartherapeutics.com
84%
First.Last@4dmoleculartherapeutics.comJohn.Doe@4dmoleculartherapeutics.com
14%
Last.First@4dmoleculartherapeutics.comDoe.John@4dmoleculartherapeutics.com
2%

Frequently Asked Questions

Where is 4D Molecular Therapeutics's headquarters located?

Minus sign iconPlus sign icon
4D Molecular Therapeutics's main headquarters is located at 5858 Horton St 455 Emeryville, California 94608 US. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is 4D Molecular Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact 4D Molecular Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is 4D Molecular Therapeutics's stock symbol?

Minus sign iconPlus sign icon
4D Molecular Therapeutics is a publicly traded company; the company's stock symbol is FDMT.

What is 4D Molecular Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
4D Molecular Therapeutics's official website is 4dmoleculartherapeutics.com and has social profiles on LinkedIn.

How much revenue does 4D Molecular Therapeutics generate?

Minus sign iconPlus sign icon
As of October 2024, 4D Molecular Therapeutics's annual revenue reached $35M.

What is 4D Molecular Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
4D Molecular Therapeutics's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does 4D Molecular Therapeutics have currently?

Minus sign iconPlus sign icon
As of October 2024, 4D Molecular Therapeutics has approximately 222 employees across 4 continents, including North AmericaEuropeAsia. Key team members include CSO: A. R.Chief Medical Officer: R. K.Chief Research & Translational Development Officer: A. S.. Explore 4D Molecular Therapeutics's employee directory with LeadIQ.

What industry does 4D Molecular Therapeutics belong to?

Minus sign iconPlus sign icon
4D Molecular Therapeutics operates in the Biotechnology Research industry.

What technology does 4D Molecular Therapeutics use?

Minus sign iconPlus sign icon
4D Molecular Therapeutics's tech stack includes Power BIMicrosoft WordRSSOpen GraphMicrosoftKinstaAmazon Web ServicesYoast SEO.

What is 4D Molecular Therapeutics's email format?

Minus sign iconPlus sign icon
4D Molecular Therapeutics's email format typically follows the pattern of . Find more 4D Molecular Therapeutics email formats with LeadIQ.

How much funding has 4D Molecular Therapeutics raised to date?

Minus sign iconPlus sign icon
As of October 2024, 4D Molecular Therapeutics has raised $300M in funding. The last funding round occurred on Feb 06, 2024 for $300M.

When was 4D Molecular Therapeutics founded?

Minus sign iconPlus sign icon
4D Molecular Therapeutics was founded in 2013.
4D Molecular Therapeutics

4D Molecular Therapeutics

Biotechnology ResearchCalifornia, United States201-500 Employees

4DMT is a clinical stage biopharma company inventing and developing innovative products to unlock the full potential of genetic medicine to treat large market and rare diseases. Our vector discovery platform Therapeutic Vector Evolution harnesses the power of directed evolution, a Nobel Prize-winning technology, with approximately one billion synthetic AAV capsid-derived sequences to invent customized and evolved vectors with improved therapeutic profiles compared to wild-type vectors. Our product design, development and manufacturing engine empowers us to efficiently create our valuable and diverse product pipeline. This combination of bold innovation and relentless execution gives 4DMT the capability to revolutionize genetic medicines and to strive for potential curative therapies. We have built a deep portfolio of genetic medicine product candidates, with five product candidates in clinical trials for seven patient populations.

We are taking genetic medicine to new heights and into new disease areas to overcome challenges not addressed by existing medicines. This incredible challenge drives our relentless and talented team. Our people are the essence of our inspiring, innovative and collaborative environment that encourages individual contributions and provides opportunities for career development. We seek the best in the industry who identify with our mission and our bold and innovative results-driven approach. Our 4 Guiding Principles drive the way we work together: 
-	Dare to Cure
-	Break Boundaries 
-	Beyond Yourself 
-	Prepare & Execute Relentlessly 

Join us in creating the future of genetic medicine.

Section iconCompany Overview

Headquarters
5858 Horton St 455 Emeryville, California 94608 US
Phone number
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
FDMT
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $300M

    4D Molecular Therapeutics has raised a total of $300M of funding over 6 rounds. Their latest funding round was raised on Feb 06, 2024 in the amount of $300M.

  • $10M$50M

    4D Molecular Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $300M

    4D Molecular Therapeutics has raised a total of $300M of funding over 6 rounds. Their latest funding round was raised on Feb 06, 2024 in the amount of $300M.

  • $10M$50M

    4D Molecular Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.